Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BREATH: Sugammadex vs Neostigmine on Breathing Recovery
NCT02845375Phase 4Completed
- Sponsor
- Leiden University Medical Center
- Start
- Sep 2016
- Primary completion
- Sep 2018
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of Sugammadex in Respiratory Insufficiency (RI) (3 arms), sponsored by Leiden University Medical Center. Primary endpoint: Hypoxic Ventilatory Response. Started Sep 2016; status: completed.
02
Drugs
Sugammadex
03
Conditions
Respiratory Insufficiency (RI)
Beyond the preview
Go deeper on NCT02845375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02845375.